LUMIT Trademark

Trademark Overview


On Friday, October 27, 2023, a trademark application was filed for LUMIT with the United States Patent and Trademark Office. The USPTO has given the LUMIT trademark a serial number of 79404481. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, March 11, 2025. This trademark is owned by LuMit Co., Ltd.. The LUMIT trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical agents affecting peripheral nervous system; dietary fiber to aid digestion; pharmaceutical preparations for the prevention of disorders of the nervous system; cardiovascular pharmaceutical preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of cardiovascular disease; eye drops; allergy medications; dietetic food substances, namely, plant-derived bioactive compounds, mitochondria-targeted supplements, and functional nutraceuticals for cardiovascular, immune, and metabolic health adapted for medical use; bath preparations for medical purposes; diagnostic agents for medical use; slimming tea for medical purposes; pharmaceutical compositions for the prevention and treatmentof mitochondrial disorders, metabolic imbalances, cardiovascular diseases, immune dysregulation, cancer, fibrosis, and neurodegenerative diseases; pharmaceutical preparations for enhancing ...

Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; Research and development of medicines.
lumit

General Information


Serial Number79404481
Word MarkLUMIT
Filing DateFriday, October 27, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, March 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical agents affecting peripheral nervous system; dietary fiber to aid digestion; pharmaceutical preparations for the prevention of disorders of the nervous system; cardiovascular pharmaceutical preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of cardiovascular disease; eye drops; allergy medications; dietetic food substances, namely, plant-derived bioactive compounds, mitochondria-targeted supplements, and functional nutraceuticals for cardiovascular, immune, and metabolic health adapted for medical use; bath preparations for medical purposes; diagnostic agents for medical use; slimming tea for medical purposes; pharmaceutical compositions for the prevention and treatmentof mitochondrial disorders, metabolic imbalances, cardiovascular diseases, immune dysregulation, cancer, fibrosis, and neurodegenerative diseases; pharmaceutical preparations for enhancing mitochondrial bioenergetics to support cardiovascular function, regulate immune responses, prevent and treat cardiac fibrosis, and improve vascular and metabolic health; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for diagnosis of mitochondrial disorders, cardiovascular diseases, immune dysregulation, cancer progression, neurodegenerative progression, and metabolic imbalances; analgesic balm; nutraceuticals for therapeutic purposes in the nature of mitochondrial energy restoration, immune system modulation, endothelial function support, and fibrosis attenuation; nutraceutical preparations for therapeutic and medical purposes in the nature of cardiovascular protection, oxidative stress regulation, immune system enhancement, and cellular metabolism optimization; pharmaceutical preparations for the treatment of parkinson's disease; antimicrobials for dermatologic use; pharmaceutical preparations for treating epidermal problems; pharmaceutical preparation for skin care; pharmaceutical preparations for skin care; antihypertensives; anti-diabetic pharmaceuticals; anti-cancer preparations; anti-sarcoma preparations; anticoagulants; anti-cancer preparations in the nature of antineoplastics; anti-dermoinfectives; antidotes; antipyretic analgesics; pharmaceutical preparations for the prevention of disorders of the respiratory system; pharmaceutical preparations for the prevention of diseases of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory organs; pharmactutical preparations in the nature of pharmaceutical compounds for treating respiratory diseases and infections; pharmaceutical products for treating respiratory diseases; inhaled pharmaceutical preparations for the treatment of respiratory diseases and infections; pharmaceutical preparations for treating respiratory diseases and infections.
Goods and ServicesPharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; Research and development of medicines.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 12, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLuMit Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, September 12, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, September 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 17, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, September 18, 2024ASSIGNED TO EXAMINER
Monday, September 23, 2024NON-FINAL ACTION WRITTEN
Tuesday, September 24, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, October 19, 2024REFUSAL PROCESSED BY IB
Friday, September 27, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 27, 2024REFUSAL PROCESSED BY MPU